Regis is positioned as a market leader with substantial scale advantages through its portfolio of residential facilities across multiple states. The company is pursuing strategic acquisitions and greenfield development while benefiting from recent government funding reforms and demographic tailwinds supporting sector growth.
Cyborg Score Rationale
Regis demonstrates solid operational fundamentals with recent revenue growth of 18% and improved operating cash flow. However, the company faces margin compression challenges, regulatory headwinds from aged care reforms, and rising staff costs that moderate the investment thesis.
Top Insights
Revenue grew 18% to AUD 668M in recent period driven by acquisitions and government funding reforms
Operating cash flow surged 40% with strong RAD (Refundable Accommodation Deposit) inflows up 108% to AUD 178.5M
Recently acquired two aged care homes in Victoria for AUD 45M as part of strategic expansion pipeline
Reintroduction of RAD retention for new residents expected to support earnings growth and fund future acquisition pipeline
Named Competitors
Residential aged care services — Major aged care operator in Australia
Residential aged care services — Aged care and retirement living provider
Home care services — Home and community aged care services
Recent Developments
(February 2026) Analysts raised fair value estimate to A$8.32 per share on improved revenue and margin assumptions
(February 2026) Announced A$0.09 fully franked interim dividend per security for H1 FY26
(2025) Expanded Victorian portfolio with acquisition of two aged care homes for A$45 million
Open the full interactive Regis Healthcare Limited report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.